Cell Death Discovery (Aug 2024)

Fatty links between multisystem proteinopathy and small VCP-interacting protein

  • Firyal Ramzan,
  • Ashish Kumar,
  • Fatima Abrar,
  • Rachel A. V. Gray,
  • Zurie E. Campbell,
  • Lucia Meng Qi Liao,
  • Anthony Dang,
  • Oluwadurotimi Akanni,
  • Colm Guyn,
  • Dale D. O. Martin

DOI
https://doi.org/10.1038/s41420-024-02118-9
Journal volume & issue
Vol. 10, no. 1
pp. 1 – 14

Abstract

Read online

Abstract Multisystem proteinopathy (MSP) is a rare, dominantly inherited disorder that includes a cluster of diseases, including frontotemporal dementia, inclusion body myopathy, and Paget’s disease of bone. MSP is caused by mutations in the gene encoding valosin-containing protein (VCP). Patients with the same mutation, even within the same family, can present with a different combination of any or all of the above diseases, along with amyotrophic lateral sclerosis (ALS). The pleiotropic effects may be linked to the greater than 50 VCP co-factors that direct VCP’s many roles in the cell. Small VCP-interacting protein (SVIP) is a small protein that directs VCP to autophagosomes and lysosomes. We found that SVIP directs VCP localization to lysosomes in an acylation-dependent manner. We demonstrate that SVIP is myristoylated at Glycine 2 and palmitoylated at Cysteines 4 and 7. Acylation of SVIP is required to mediate cell death in the presence of the MSP-associated VCP variant (R155H-VCP), whereas blocking SVIP myristoylation prevents cytotoxicity. Therefore, SVIP acylation may present a novel target in MSP.